Inactive Instrument

Luzhou Bio-chem Technology Limited

L46

SG1S94928862

Luzhou Bio-chem Technology Limited Provides Earnings Guidance for the Second Quarter Ended June 30, 2018

August 01, 2018 at 05:14 am

Luzhou Bio-chem Technology Limited provided earnings guidance for the second quarter ended June 30, 2018. The company would like to advise shareholders that the Company and its subsidiaries are expected to report a net loss for second quarter of fiscal year 2018.

Latest news about Luzhou Bio-chem Technology Limited

Niu Ji Xing, Executive Chairman and Chief Executive Officer of Luzhou Bio-chem Technology Limited, completed the acquisition of remaining 58.8% stake in Luzhou Bio-chem Technology Limited.	20-09-13	CI
Luzhou Bio-Chem Technology Limited Reports Earnings Results for the Half Year Ended June 30, 2020	20-08-14	CI
Niu Ji Xing, Executive Chairman and Chief Executive Officer of Luzhou Bio-chem Technology Limited, intends to make a voluntary conditional general offer to acquire the remaining 58.8% stake in Luzhou Bio-chem Technology Limited for SGD 10.5 million,	20-06-29	CI
Luzhou Bio-Chem Technology Limited Receives Approvals from the Local Authorities to Resume Operations	20-03-02	CI
Luzhou Bio-Chem Technology Limited Reports Earnings Results for the Fourth Quarter Ended December 31, 2019	20-02-26	CI
Luzhou Bio-Chem Technology Limited Announces Unaudited Group Earnings Results for the Third Quarter and Nine Months Ended September 30, 2019	19-11-12	CI
Luzhou Bio-Chem Technology Limited Provides Earnings Guidance for the Third Quarter Ended 30 September 2019	19-10-25	CI
Luzhou Bio-Chem Technology Limited Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2019	19-08-01	CI
Luzhou Bio-Chem Technology Limited Provides Group Earnings Guidance for the Second Quarter Ended June 30, 2019	19-07-23	CI
Luzhou Bio-Chem Technology Limited Reports Unaudited Group Earnings Results for the First Quarter Ended March 31, 2019	19-05-15	CI
Luzhou Bio-Chem Technology Limited Provides Earnings Guidance for the First Quarter of 2019	19-05-07	CI
Luzhou Bio-chem Technology Limited Pays No Dividend for the Financial Year ended 31 December 2018	19-04-08	CI
Luzhou Bio-Chem Technology Limited Reports Earnings Results for the Fourth Quarter Ended December 31, 2018	19-02-28	CI
Luzhou Bio-Chem Technology Limited Announces Incorporation of New Subsidiary	19-02-15	CI
Luzhou Bio-Chem Technology Limited Provides Group Earnings Guidance for the Fourth Quarter Ended December 31, 2018	19-02-01	CI
Luzhou Bio-chem Technology Limited Announces the Appointment of Koh Pee Keat as A Chief Financial Officer	19-01-01	CI
Luzhou Bio-Chem Technology Limited Announces Unaudited Group Earnings Results for the Third Quarter and Nine Months Ended September 30, 2018	18-11-13	CI
Luzhou Bio-Chem Technology Limited Announces Group Earnings Results for the Second Quarter and Six Months Ended June 30, 2018	18-08-13	CI
Luzhou Bio-chem Technology Limited Provides Earnings Guidance for the Second Quarter Ended June 30, 2018	18-08-01	CI
Luzhou Bio-chem Technology Limited Announces Resignation of Li Na as Group Senior Finance Manager of Accounting, Reporting, Financing and Other Financial Functions	18-05-28	CI
Luzhou Bio-chem Technology Limited Reports Unaudited Earnings Results for the First Quarter Ended March 31, 2018	18-04-27	CI
Luzhou Bio-Chem Technology Limited Announces Audited Consolidated Earnings Results for the Year Ended December 31, 2017	18-04-08	CI
Luzhou Bio-Chem Technology Limited Announces No Dividend for the Year Ended December 31, 2017	18-02-27	CI
Luzhou Bio-chem Technology Limited Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Year Ended December 31, 2017	18-02-27	CI
Luzhou Bio-Chem Technology Limited Provides Earnings Guidance for the Fourth Quarter Ended December 31, 2017	18-02-12	CI

Chart Luzhou Bio-chem Technology Limited

Duration

Period

Chart Luzhou Bio-chem Technology Limited

More charts

Company Profile

Luzhou Bio-chem Technology Limited (Luzhou) is a Singapore-based investment holding company. The Company is a corn refiner, and producer of maltose-related products and other corn sweeteners in the People's Republic of China (PRC). The Company's segments include Corn refining, which includes the manufacture and sale of corn sweeteners, corn starch, corn oil and related products; Animal feeds, which includes the manufacture of feed for farm animals; Other products, which includes manufacture and sale of amino acids, and provision of engineering services and construction of industrial machinery and equipment, and Corporate. Its products include sugar alcohol, corn oil, amino acids and high fructose corn syrup 55. Luzhou serves a diverse customer base across various industries, including food and beverage, fermentation, medical and pharmaceutical sectors. It has a total production capacity of 1,040,000 tons per annum through approximately six production facilities in the PRC.

Sector

Food Processing

More about the company

Sector Other Food Processing

	1st Jan change	Capi.
NESTLÉ S.A.	-2.00%	277B
MONDELEZ INTERNATIONAL, INC.	-5.38%	91.92B
KRAFT HEINZ	-4.35%	42.95B
DANONE	+0.75%	41.25B
THE HERSHEY COMPANY	+6.11%	40.01B
GENERAL MILLS, INC.	+5.54%	38.81B
ARCHER-DANIELS-MIDLAND COMPANY	-13.54%	30.87B
NESTLÉ INDIA LIMITED	-11.43%	27.21B
ASSOCIATED BRITISH FOODS PLC	+7.73%	24.19B

Other Food Processing